Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review-Reference-Cited by-同舟云学术

Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review

Published:2024-03 Issue:3 Volume:1870 Page:167037
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Laddha Ankit P.,Dzielak Lindsey,Lewis Cedric,Xue Raymond,Manautou José E.

Publisher

Elsevier BV

Reference98 articles.

1. Liver transporters in hepatic drug disposition: An update;Li;Curr. Drug Metab.,2009

2. Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium, Clin Pharmacol Ther;Brouwer,2022

3. The solute carrier family SLC10: more than a family of bile acid trans- porters regarding function and phylogenetic relationships;Geyer;Naunyn Schmiedebergs Arch. Pharmacol.,2006

4. Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice;Xiong;J. Hepatol.,2014

5. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine;Kim;J. Lipid Res.,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative genomic and metabolomic analysis reveals the potential of a newly isolated Enterococcus faecium B6 involved in lipogenic effects;Gene;2024-11

2. Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs;Frontiers in Pharmacology;2024-07-24

3. Advances in mesenchymal stem cell therapy and natural antioxidants for hepatic fibrosis: A comprehensive review;Pharmacological Research - Reports;2024-03